| FSLEX | RYPAX | FSLEX / RYPAX | |
| Total Expense Ratio | 0.68 | 1.63 | 42% |
| Annual Report Gross Expense Ratio | 0.68 | 1.68 | 40% |
| Fund Existence | 37 years | 28 years | - |
| Gain YTD | 8.800 | 4.914 | 179% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 662M | 5.84M | 11,330% |
| Annual Yield % from dividends | 0.37 | 0.05 | 703% |
| Returns for 1 year | 15.27 | 9.40 | 162% |
| Returns for 3 years | 69.32 | 19.32 | 359% |
| Returns for 5 years | 46.75 | -16.62 | -281% |
| Returns for 10 years | 156.99 | 41.98 | 374% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| DWOIX | 20.34 | N/A | N/A |
| BNY Mellon Research Growth I | |||
| JLCFX | 74.98 | N/A | N/A |
| JHancock Fundamental Large Cap Core R4 | |||
| VDMAX | 11.52 | N/A | N/A |
| Virtus KAR Developing Markets A | |||
| MNOPX | 34.47 | N/A | N/A |
| Morgan Stanley Inst International Opp R6 | |||
| CWSRX | 23.24 | N/A | N/A |
| Carillon Chartwell Small Cap Growth R-6 | |||